Athira Pharma Inc (NAS:ATHA)
$ 0.5102 0.0198 (4.04%) Market Cap: 19.60 Mil Enterprise Value: -71.51 Mil PE Ratio: 0 PB Ratio: 0.23 GF Score: 42/100

Athira Pharma Inc at Stifel CNS Days (Virtual) Transcript

Mar 28, 2022 / 06:30 PM GMT
Release Date Price: $12.89 (+1.18%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ATHA.OQ - Athira Pharma Inc
Athira Pharma Inc at Stifel CNS Days (Virtual)
Mar 28, 2022 / 06:30PM GMT

=====================
Conference Call Participants
=====================
* Paul Matteis
Stifel Nicolaus - Analyst
* Mark Litton
Athira Pharma, Inc. - President & CEO
* Hans Mobius
Athira Pharma, Inc. - Chief Medical Officer
* Kevin Church
Athira Pharma, Inc. - EVP, Research

=====================
Presentation
--------------------------------------------------------------------------------
Paul Matteis, Stifel Nicolaus - Analyst [1]
--------------------------------------------------------------------------------
Great. Good afternoon, everybody. Thank you for listening to all the panels today, I appreciate it. It would take too long to do extensive intros, but it's my pleasure to have four members of the Athira executive team with me. And I'm assuming many folks know the company well. But Mark, let's kick it off with just a high-level overview, an update
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot